# Clinical Trial Landscape: 10_gastric_her2_msi_high

*Generated: 2026-01-05 06:59:40*

## Summary

- **Total Trials**: 100
- **Flagged for Review**: 0
- **Search Terms Used**: 11

## Phase Distribution

| Phase | Count | Distribution |
|-------|-------|--------------|
| Phase 1/Phase 2 | 22 | ████ 22.0% |
| Phase 2 | 22 | ████ 22.0% |
| Phase 1 | 20 | ████ 20.0% |
| Not Applicable | 12 | ██ 12.0% |
| Phase 3 | 12 | ██ 12.0% |
| Unknown | 9 | █ 9.0% |
| Early Phase 1 | 2 |  2.0% |
| Phase 4 | 1 |  1.0% |

## Status Distribution

- **Recruiting**: 93 (93.0%)
- **Not yet recruiting**: 4 (4.0%)
- **Enrolling by invitation**: 3 (3.0%)

## Top Sponsors

| Sponsor | Trial Count |
|---------|-------------|
| National Cancer Institute (NCI) | 5 |
| University of Chicago | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Hoffmann-La Roche | 3 |
| Washington University School of Medicine | 3 |
| GlaxoSmithKline | 3 |
| Novartis Pharmaceuticals | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns | 2 |
| SWOG Cancer Research Network | 2 |
| Medical College of Wisconsin | 2 |
| NRG Oncology | 2 |
| AstraZeneca | 2 |
| AbbVie | 2 |
| M.D. Anderson Cancer Center | 2 |

## Interventions

| Intervention | Occurrences |
|--------------|-------------|
| Nivolumab | 9 |
| Pembrolizumab | 7 |
| Biospecimen Collection | 7 |
| Letrozole | 6 |
| Abemaciclib | 5 |
| Bevacizumab | 5 |
| Computed Tomography | 5 |
| Paclitaxel | 5 |
| Palbociclib | 4 |
| Inavolisib | 4 |
| Dostarlimab | 4 |
| Questionnaire Administration | 4 |
| Magnetic Resonance Imaging | 4 |
| Regorafenib | 3 |
| Relatlimab | 3 |
| Placebo | 3 |
| Echocardiography Test | 3 |
| Multigated Acquisition Scan | 3 |
| Positron Emission Tomography | 3 |
| pembrolizumab | 3 |

## Geographic Distribution

| Country | Trial Count |
|---------|-------------|
| United States | 100 |
| South Korea | 25 |
| Spain | 22 |
| France | 18 |
| Canada | 18 |
| Japan | 16 |
| Australia | 15 |
| Germany | 13 |
| China | 13 |
| Taiwan | 13 |
| Italy | 12 |
| United Kingdom | 12 |
| Israel | 11 |
| Brazil | 9 |
| Belgium | 8 |

## Search Term Provenance

| Term | Source | Confidence |
|------|--------|------------|
| HER2 positive | manual | 1.0 |
| HER2positive | manual | 0.9 |
| HER2-positive | manual | 0.9 |
| MSI-High | manual | 1.0 |
| gastric cancer | manual | 1.0 |
| HER2 positive gastric cancer | manual | 1.0 |
| MSI-High gastric cancer | manual | 1.0 |
| HER2 positive gastric adenocarcinoma | llm | 0.9 |
| stomach cancer | llm | 0.8 |
| gastric adenocarcinoma | llm | 0.8 |
| HER2 | llm | 0.9 |

## All Trials

| NCT ID | Phase | Status | Sponsor | Title |
|--------|-------|--------|---------|-------|
| [NCT04383262](https://clinicaltrials.gov/study/NCT04383262) | Phase 2 | Not yet recruiting | Medical College of W... | A 12-Week Randomized, Double-Blind,... |
| [NCT06224673](https://clinicaltrials.gov/study/NCT06224673) | Phase 2 | Not yet recruiting | Laura Huppert, MD, B... | Phase II Open-label Study of ARX788... |
| [NCT06348134](https://clinicaltrials.gov/study/NCT06348134) | Phase 2 | Not yet recruiting | University of Chicag... | Assessing the Efficacy and Safety o... |
| [NCT06084780](https://clinicaltrials.gov/study/NCT06084780) | Phase 2 | Not yet recruiting | Case Comprehensive C... | Prospective Case Series of Intestin... |
| [NCT04107077](https://clinicaltrials.gov/study/NCT04107077) | Phase 2 | Recruiting | University of Chicag... | A Phase IIa Study of Laparoscopic H... |
| [NCT06503146](https://clinicaltrials.gov/study/NCT06503146) | Phase 2 | Recruiting | National Cancer Inst... | 18F-Fibroblast Activation Protein I... |
| [NCT06807437](https://clinicaltrials.gov/study/NCT06807437) | Phase 3 | Recruiting | SWOG Cancer Research... | A Randomized Phase III Blinded Tria... |
| [NCT06710756](https://clinicaltrials.gov/study/NCT06710756) | Phase 1/Phase 2 | Recruiting | Perspective Therapeu... | A Phase I/IIa Image-Guided, Alpha-P... |
| [NCT06790693](https://clinicaltrials.gov/study/NCT06790693) | Phase 3 | Recruiting | Hoffmann-La Roche | A Phase III, Multicenter, Randomize... |
| [NCT06726148](https://clinicaltrials.gov/study/NCT06726148) | Phase 1/Phase 2 | Recruiting | Novartis Pharmaceuti... | An Open-label, Multi-center, Phase ... |
| [NCT06552260](https://clinicaltrials.gov/study/NCT06552260) | Early Phase 1 | Recruiting | Ugonma Chukwueke | A Surgical Window of Opportunity Cl... |
| [NCT06671912](https://clinicaltrials.gov/study/NCT06671912) | Phase 3 | Recruiting | Alliance for Clinica... | LoTam: A Randomized, Phase III Clin... |
| [NCT06731998](https://clinicaltrials.gov/study/NCT06731998) | Not Applicable | Recruiting | Allegheny Singer Res... | Evaluating Optimal Perioperative Pa... |
| [NCT06374459](https://clinicaltrials.gov/study/NCT06374459) | Phase 1/Phase 2 | Recruiting | Washington Universit... | A Phase Ib/II Trial of Zunsemetinib... |
| [NCT06695845](https://clinicaltrials.gov/study/NCT06695845) | Phase 2 | Recruiting | Jazz Pharmaceuticals | A Phase 2, Open-label, Multicenter ... |
| [NCT06760637](https://clinicaltrials.gov/study/NCT06760637) | Phase 3 | Recruiting | Pfizer | AN INTERVENTIONAL, OPEN-LABEL, RAND... |
| [NCT06710847](https://clinicaltrials.gov/study/NCT06710847) | Phase 1/Phase 2 | Recruiting | GlaxoSmithKline | A Phase 1/2 First-Time-in-Human, Op... |
| [NCT06691035](https://clinicaltrials.gov/study/NCT06691035) | Phase 1 | Recruiting | H. Lee Moffitt Cance... | Immunologic Targeting of Native and... |
| [NCT06625515](https://clinicaltrials.gov/study/NCT06625515) | Phase 1 | Recruiting | Accent Therapeutics | A Phase 1/2, Open-Label, Dose-Escal... |
| [NCT06551116](https://clinicaltrials.gov/study/NCT06551116) | N/A | Recruiting | Abramson Cancer Cent... | QuantifyHER: Quantitative Immunoflu... |
| [NCT06361940](https://clinicaltrials.gov/study/NCT06361940) | Phase 2 | Recruiting | Medical College of W... | Molecular Analyses to Predict Pathw... |
| [NCT05977036](https://clinicaltrials.gov/study/NCT05977036) | Not Applicable | Recruiting | Washington Universit... | BettER: Biomarker Driven Early Ther... |
| [NCT06362369](https://clinicaltrials.gov/study/NCT06362369) | Phase 1/Phase 2 | Recruiting | 7 Hills Pharma, LLC | A Phase 1b/2a Multi-Center, Dose Es... |
| [NCT06439693](https://clinicaltrials.gov/study/NCT06439693) | Phase 2 | Recruiting | Dana-Farber Cancer I... | A Single-Arm, Phase II Study of Seq... |
| [NCT06445972](https://clinicaltrials.gov/study/NCT06445972) | Phase 1/Phase 2 | Recruiting | Merck Sharp & Dohme ... | A Phase 1/2 Open-Label, Umbrella Pl... |
| [NCT06006923](https://clinicaltrials.gov/study/NCT06006923) | Phase 2 | Recruiting | Anwaar Saeed | Randomized Trial of Regorafenib in ... |
| [NCT06188585](https://clinicaltrials.gov/study/NCT06188585) | Not Applicable | Recruiting | Medtronic - MITG | Randomized Controlled Multi-Center ... |
| [NCT06126276](https://clinicaltrials.gov/study/NCT06126276) | Phase 2 | Recruiting | National Cancer Inst... | A Randomized Trial of Neratinib, A ... |
| [NCT06253871](https://clinicaltrials.gov/study/NCT06253871) | Phase 1 | Recruiting | Iambic Therapeutics,... | A Phase 1/1b Study of IAM1363 in Pa... |
| [NCT06257264](https://clinicaltrials.gov/study/NCT06257264) | Phase 1 | Recruiting | BeiGene | A Phase 1a/1b Study of BG-68501, a ... |
| [NCT05996107](https://clinicaltrials.gov/study/NCT05996107) | Phase 1 | Recruiting | University of Michig... | A Phase 1B Study of Ribociclib Admi... |
| [NCT06138808](https://clinicaltrials.gov/study/NCT06138808) | N/A | Enrolling by invitation | Duke University | Prognostic Value of the 5-SENSE Sco... |
| [NCT05986604](https://clinicaltrials.gov/study/NCT05986604) | Not Applicable | Recruiting | University of Califo... | NIA_Improving Sleep and Circadian F... |
| [NCT06219941](https://clinicaltrials.gov/study/NCT06219941) | Phase 2 | Recruiting | AstraZeneca | A Phase II, Open-label, Multi-centr... |
| [NCT05802056](https://clinicaltrials.gov/study/NCT05802056) | Phase 1 | Recruiting | Mayo Clinic | COordinated Nivolumab and Intraperi... |
| [NCT06084481](https://clinicaltrials.gov/study/NCT06084481) | Phase 1 | Recruiting | AbbVie | A Phase 1 Open-Label Study to Evalu... |
| [NCT06127979](https://clinicaltrials.gov/study/NCT06127979) | Not Applicable | Recruiting | Memorial Sloan Kette... | Differential Changes in Ki67 Betwee... |
| [NCT06047379](https://clinicaltrials.gov/study/NCT06047379) | Phase 1/Phase 2 | Recruiting | Neonc Technologies, ... | An Open-label Phase 1/2 Dose Findin... |
| [NCT06062498](https://clinicaltrials.gov/study/NCT06062498) | Phase 2 | Recruiting | Northwestern Univers... | Randomized Phase II Study of Elaces... |
| [NCT05636618](https://clinicaltrials.gov/study/NCT05636618) | Phase 1/Phase 2 | Recruiting | Perspective Therapeu... | A Phase I/IIa First-in-Human Study ... |
| [NCT05894239](https://clinicaltrials.gov/study/NCT05894239) | Phase 3 | Recruiting | Hoffmann-La Roche | A Phase III, Multicenter, Randomize... |
| [NCT05879926](https://clinicaltrials.gov/study/NCT05879926) | Phase 3 | Recruiting | NRG Oncology | A Phase III Adjuvant Trial Evaluati... |
| [NCT05986279](https://clinicaltrials.gov/study/NCT05986279) | Not Applicable | Recruiting | University of Montan... | Improving Psychological and Vestibu... |
| [NCT05985148](https://clinicaltrials.gov/study/NCT05985148) | Phase 1 | Recruiting | Memorial Sloan Kette... | A Phase I Dose Escalation Trial for... |
| [NCT05855200](https://clinicaltrials.gov/study/NCT05855200) | Phase 3 | Recruiting | GlaxoSmithKline | A Phase 3, Open-Label, Randomized S... |
| [NCT05959291](https://clinicaltrials.gov/study/NCT05959291) | Not Applicable | Recruiting | University of Miami | Free-HER: Discontinuation of Mainte... |
| [NCT05838768](https://clinicaltrials.gov/study/NCT05838768) | Phase 1 | Recruiting | Novartis Pharmaceuti... | An Open-label, Multi-center Phase I... |
| [NCT05520099](https://clinicaltrials.gov/study/NCT05520099) | N/A | Recruiting | Elephas | Observational Basket Trial to Colle... |
| [NCT05187182](https://clinicaltrials.gov/study/NCT05187182) | Phase 1 | Recruiting | Washington Universit... | Phase I Trial of CA-4948 in Combina... |
| [NCT05706025](https://clinicaltrials.gov/study/NCT05706025) | Not Applicable | Enrolling by invitation | University of Colora... | Pilot Study to Evaluate Utility of ... |

*... and 50 more trials (see trials.csv for full list)*
